Search Results Search Sort by RelevanceMost Recent Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606. Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777. Case and Commentary Jun 2011 Herbal Supplements as Placebos Valerie Jones, MD Even if a placebo is safe, it should not be employed as a way of mollifying patients or glossing over underlying causes of illness. Virtual Mentor. 2011;13(6):354-358. doi: 10.1001/virtualmentor.2011.13.6.ccas3-1106. Health Law May 2010 Silicone Breast Implant Litigation Kristin E. Schleiter, JD, LLM Public opinion, profit-seeking professionals, and medical evidence all played critical roles in the rise and fall of silicone breast implant lawsuits. Virtual Mentor. 2010;12(5):389-394. doi: 10.1001/virtualmentor.2010.12.5.hlaw1-1005.
Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606.
Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777.
Case and Commentary Jun 2011 Herbal Supplements as Placebos Valerie Jones, MD Even if a placebo is safe, it should not be employed as a way of mollifying patients or glossing over underlying causes of illness. Virtual Mentor. 2011;13(6):354-358. doi: 10.1001/virtualmentor.2011.13.6.ccas3-1106.
Health Law May 2010 Silicone Breast Implant Litigation Kristin E. Schleiter, JD, LLM Public opinion, profit-seeking professionals, and medical evidence all played critical roles in the rise and fall of silicone breast implant lawsuits. Virtual Mentor. 2010;12(5):389-394. doi: 10.1001/virtualmentor.2010.12.5.hlaw1-1005.